Genkyotex Announces 2020 Annual Financial Results And Provides Corporate Update
Genkyotex provides Q4 business update and reports cash position
Genkyotex announces update for near term clinical development plan for setanaxib
Genkyotex announces positive Phase 1 results demonstrating a favorable safety and pharmacokinetic profile of high-dose setanaxib
Ask us your questions
Suscribe to Newsletter
